Literature DB >> 19331014

Recognition, recollection, familiarity and executive function in medicated patients with moderate Parkinson's disease.

Nicola M J Edelstyn1, Andrew R Mayes, Laura Condon, Michelle Tunnicliffe, Simon J Ellis.   

Abstract

There is conflicting evidence about whether Parkinson's disease (PD) is associated with deficiencies in recognition memory (RM) and the processes which underlie it, namely recollection (a form of recall) and familiarity (a feeling of memory in the absence of recall). The aims of the current study were to examine forced-choice verbal RM (assessed with the Warrington Recognition memory Test), yes-no RM, recollection, familiarity and executive functioning in 17 patients with moderate PD and 17 healthy volunteers matched for age and premorbid intelligence. We predicted that patients with moderate PD would display a significant recollection deficit on the yes-no RM test, because their strategic memory processing that depends on executive functioning and is necessary for efficient encoding and/or retrieval, was disrupted. In contrast, familiarity memory, which is not dependent on these processes, and forced-choice RM (which is largely dependent on familiarity) should show higher levels of preservation. We also predicted that recollection should be correlated with severity of executive dysfunction. Our findings revealed that the PD patients were as likely to accurately discriminate between targets and distractors as the healthy volunteers on both RM tests. However, the PD patients were significantly less reliant on recollection-driven recognition decisions on the yes-no RM test when compared with the healthy control group. The patients also displayed executive function deficits, but these were not correlated with recollection. The extent to which the PD patients' reliance on familiarity at the expense of recollection is explained by impairments in strategic memory processes/executive function and/or medial temporal lobe retrieval processes needs further exploration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19331014     DOI: 10.1348/174866407x182565

Source DB:  PubMed          Journal:  J Neuropsychol        ISSN: 1748-6645            Impact factor:   2.864


  6 in total

1.  Damage to the lateral prefrontal cortex impairs familiarity but not recollection.

Authors:  Mariam Aly; Andrew P Yonelinas; Mark M Kishiyama; Robert T Knight
Journal:  Behav Brain Res       Date:  2011-07-30       Impact factor: 3.332

Review 2.  Striatal contributions to declarative memory retrieval.

Authors:  Jason M Scimeca; David Badre
Journal:  Neuron       Date:  2012-08-09       Impact factor: 17.173

Review 3.  Episodic recognition memory and the hippocampus in Parkinson's disease: A review.

Authors:  Tanusree Das; Jaclyn J Hwang; Kathleen L Poston
Journal:  Cortex       Date:  2018-12-04       Impact factor: 4.027

4.  Dopamine and Consolidation of Episodic Memory: Timing is Everything.

Authors:  John Grogan; Rafal Bogacz; Demitra Tsivos; Alan Whone; Elizabeth Coulthard
Journal:  J Cogn Neurosci       Date:  2015-06-23       Impact factor: 3.225

5.  Feasibility of a randomized single-blind crossover trial to assess the effects of the second-generation slow-release dopamine agonists pramipexole and ropinirole on cued recall memory in idiopathic mild or moderate Parkinson's disease without cognitive impairment.

Authors:  Thomas A Shepherd; Nicola M J Edelstyn; Laura Longshaw; Julius Sim; Keira Watts; Andrew R Mayes; Michael Murray; Simon J Ellis
Journal:  Pilot Feasibility Stud       Date:  2017-07-06

6.  Mnemonic Similarity Task to study episodic memory in Parkinson's disease.

Authors:  Tanusree Das; Nessa Kim; Colin McDaniel; Kathleen L Poston
Journal:  Clin Park Relat Disord       Date:  2020-06-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.